A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk
Nov 30, 2023
06:58
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.
Science, Spoken